All News

In this article, we'll explain how healthcare organizations can drive patient engagement and satisfaction while improving outcomes by supporting the whole person in one comprehensive digital solution.

The study, which followed 51 people with HIV who received kidney transplants from deceased donors with HIV in South Africa, found that the transplants produced long-term success, with high rates of overall survival and kidney graft survival after 5 years.

Research presented at the European Respiratory Society Conference 2019 details the novel use of a single inhaler combining 3 therapies, as opposed to 2, in 2 clinical studies on patients with severe asthma.

Presented at the European Respiratory Society International Congress, the findings suggest that polycystic ovary syndrome could be responsible for lower lung capacity in some women, which heightens the risk for cardiovascular disease and higher mortality rates, even in the absence of chronic respiratory conditions.

The Government Accountability Office (GAO)’s analysis of Indian Health Service (IHS) data shows that from fiscal years 2013 through 2018, the percentage of patients at federally operated IHS hospitals and health centers who reported having health insurance coverage increased an average of 14 percentage points, from 64% in 2013 to 78% in 2018.

The guiding principle of a lifestyle medicine program is based on addressing the underlying causes of illnesses on multiple levels. The bigger picture is to prevent chronic illnesses in the first place—a major failing of the medical system and medical education.

Children with spinal muscular atrophy (SMA) who require noninvasive ventilation had more severe impairments in respiratory function than those who do not, according to findings of a new study.

The Drug Enforcement Administration (DEA) allowed large increases in the production of opioids even as the number of opioid-related deaths in the country soared; a federal judge has temporarily blocked Georgia’s new abortion law that was set to go into effect January 1; the United Parcel Service (UPS) has received approval from the Federal Aviation Administration to start setting up drones to deliver health supplies.

Researchers said the previous results on high sensitivity C-reactive protein and migraine are mixed, and the relationship to insomnia limited; the aim of this study was to evaluate the cross-sectional association between hs-CRP and types of headache, and to see whether the relationship to insomnia could be reproduced.

As practices work to provide the best care for their patients while also containing costs, it has become clear that the old ways of doing things won’t cut it.

Ozanimod, under development to treat relapsing-remitting multiple sclerosis (RRMS), has greater efficacy on the annualized relapse rate (ARR) than most other first-line disease-modifying therapies (DMTs), according to 2 abstracts presented at ECTRIMS 2019, the 35th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis.

Medicare cut payments to 2583 hospitals for penalties related to 30-day patient readmissions; a judge delivers a mixed ruling on Virginia abortion law; a study finds vitamin A is linked to a lower risk of squamous cell carcinoma.

Pirfenidone was shown to potentially benefit patients with uILD in a phase 2 trial, according to research presented at the European Respiratory Society Congress 2019 in Madrid, Spain.

The new indication is based on results of the CREDENCE trial, which found that canagliflozin reduced the risk of renal failure or death by 30% in those that had both type 2 diabetes and diabetic kidney disease.

According to results of a survey asking 1300 Americans about their perceptions and knowledge of sleep disorders like narcolepsy, many respondents were not familiar with common symptoms of the disease and their understanding was often shaped by television shows or movies.

Knowing who may respond to tildrakizumab early on may help providers and patients decide whether to continue with treatment, the researchers said.

Here are 5 interesting findings from the September 2019 issue of AJMC®.

Here are the top 5 articles for the month of September.

EpiPen manufacturer settles $30 million claim; THC-containing brands cited as potential cause of vaping epidemic; Idaho submits work-requirement waiver for Medicaid expansion.

Since healthcare benefit costs continue to rise, large employers are increasing efforts to stem the increases, according to the annual survey by the National Business Group on Health.

According to the findings, adding poly (ADP ribose) polymerase (PARP) inhibitor olaparib to bevacizumab extended progression-free survival (PFS) in women with advanced stage ovarian cancer, with or without a BRCA mutation.

Cognitive status may be affected by the relationship of Parkinson disease (PD) and affective theory of mind through the involvement of visuospatial abilities (VSA), a recent study reported.

A recent study investigating the cardiovascular contribution to COPD symptoms and their relationship to a patient's diagnostic status found that patients with suspicious echocardiographic findings were undiagnosed and untreated.

The new indication is the seventh overall for the therapy, according to Janssen.

An immunoglobulin G (IgG) elimination diet combined with probiotics may be effective and beneficial for patients with both migraine and irritable bowel syndrome (IBS), according to a recent study,

Adherence to documenting asthma severity or control and providing ample education to patients was low among physicians from 2012-2015, with primary care providers monitoring nearly two-thirds of asthma-related visits, according to a federal report.

During a panel discussion on defining, standardizing, and reporting quality in cancer care during the National Comprehensive Cancer Network Policy Summit held September 12 in Washington, DC, it became clear that stakeholders of all backgrounds have set their focus on one type of metric in particular: patient-reported outcomes.

This week, the top managed care news included state and federal crackdowns on vaping that forced out the president of Juul; FDA approved a groundbreaking diabetes treatment; Medicare Advantage premiums will decline for 2020.